Holen Sie sich die Stockscreener-App
10.09
2.42%
-0.25
Vorhandelsmarkt:
10.29
0.20
+1.98%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RCEL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$10.34
Offen:
$10.15
24-Stunden-Volumen:
413.46K
Relative Volume:
0.94
Marktkapitalisierung:
$312.05M
Einnahmen:
$72.35M
Nettoeinkommen (Verlust:
$-45.34M
KGV:
-6.4247
EPS:
-1.5705
Netto-Cashflow:
$-32.43M
1W Leistung:
+25.97%
1M Leistung:
+96.30%
6M Leistung:
+110.65%
1J Leistung:
+115.14%
1-Tages-Spanne:
$9.89
$10.34
1-Wochen-Bereich:
$7.66
$10.41
52-Wochen-Spanne:
$3.22
$10.41
Avita Medical Inc Stock (RCEL) Company Profile
Firmenname
Avita Medical Inc
Sektor
Branche
Telefon
661-568-1317
Adresse
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
10.09 | 319.78M | 72.35M | -45.34M | -32.43M | -1.5705 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-05 | Eingeleitet | Northland Capital | Outperform |
| 2025-11-20 | Hochstufung | BTIG Research | Sell → Neutral |
| 2025-08-08 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-12-24 | Eingeleitet | D. Boral Capital | Buy |
| 2024-04-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-27 | Eingeleitet | BofA Securities | Buy |
| 2020-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-03 | Eingeleitet | BTIG Research | Buy |
Alle ansehen
Avita Medical Inc Aktie (RCEL) Neueste Nachrichten
Avita Medical (RCEL) Stock Forum and Discussion - Moomoo
RCEL Maintained by TD Cowen -- Price Target Raised to $14.00 - GuruFocus
TD Cowen raises Avita Medical stock price target on PermeaDerm data - Investing.com Canada
RCEL Maintained by BTIG -- Price Target Raised to $11.00 - GuruFocus
AVITA Medical (NASDAQ:RCEL) Raises Full-Year Guidance on Spray-On Skin Adoption - Kalkine Media
Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
BTIG raises Avita Medical stock price target on positive trial data - Investing.com Canada
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Raises Target Price to $14 - Moomoo
Avita Medical Inc. (NASDAQ:RCEL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AVITA Medical (ASX:AVH) Jumps 23.18% as Shares Extend a 67% One-Year Recovery - Kalkine
AVITA Medical (ASX:AVH) Soars 22.73% as Revenue Upgrade and Cash-Flow Target Reset the Conversation - Kalkine
AVITA Medical (ASX: AVH) Reports 70% Cost Advantage for PermeaDerm in Randomized Study - Kalkine
AVITA Medical's PermeaDerm-I Study Reveals 70% Cost Savings Over Cadaveric Allograft with Equivalent Clinical Results - Kalkine Media
AVITA Medical Inc to Host Key Opinion Leader Webinar Transcript - GuruFocus
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes - Investing News Network
RCEL Looks 21.8% Undervalued on GF Value™ - GuruFocus
Avita Medical Says PermeaDerm Study Meets Primary Endpoint, Showing 70% Cost Reduction - marketscreener.com
AVITA Medical’s PermeaDerm shows 70% cost savings over allograft By Investing.com - Investing.com Canada
A wound matrix cut prep time 96% with outcomes comparable to cadaver grafts - Stock Titan
AVITA Medical Inc Annual Shareholders Meeting Transcript - GuruFocus
RCEL Q2 2026 Earnings: Narrower Quarterly Loss Beats Estimates; Shares Slip 2%Earnings Quality Analysis - Vinanet
AVITA Medical, Inc. (RCEL) Shareholder/Analyst CallSlideshow (NASDAQ:RCEL) 2026-08-16 - Seeking Alpha
Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18% - MarketBeat
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds - MarketBeat
RCEL Q2 2026 Earnings: EPS Beat of 14.5% Overshadowed by a 2% Stock DeclineEarnings Expansion Phase - Vinanet
AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript - AOL.com
Avita Medical (RCEL) Rises 3.57% as Shares Rebound Toward Key ResistanceStock Surge Alerts - Vinanet
Avita Medical (RCEL) Dips to $8.12 as Support at $7.71 Moves into FocusPCR Extreme - Vinanet
Avita Medical Inc. (ASX:AVH) Share Price Remains Unchanged as Stock Trades Within Daily Range - Kalkine
AVITA Medical at canaccord growth conference: growth resumes By Investing.com - Investing.com Canada
AVITA Medical Inc (ASX:AVH) Shares Reach 52-Week High at AUD 2.30 - Kalkine
Form 8K Avita Medical Ltd For: 11 August By Investing.com - Investing.com India
Avita Medical Issues 7,260 Restricted US Stock Units to Key Management Personnel - Kalkine
Avita Medical amends agreement with Stedical Scientific to expand distribution rights - Investing.com Nigeria
Avita Medical Inc. (ASX:AVH) Share Market Overview and Biotechnology Sector Profile - Kalkine
Avita Medical Target Price Raised 52% to A$1.90/Share by Canaccord Genuity>AVH.AU - Moomoo
Avita Medical Company Profile & Introduction - Moomoo
AVITA Medical to Showcase at Canaccord Genuity 46th Annual Growth Conference in Boston - Kalkine Media
Avita Medical Upgraded to Speculative Buy From Speculative Hold by Bell Potter - Moomoo
AVITA Medical to Present at Canaccord Genuity 46th Annual Growth Conference in Boston - Kalkine
Avita Medical(RCEL) Stock Options Chain | Quotes & News - Moomoo
Can AVITA Medical (ASX:AVH) Turn RECELL Momentum Into More? - Kalkine Media
AVITA Medical to host investor webinar on Q2 20... - Pluang
Avita Medical hosts investor webinar briefing led by CEO Cary Vance, CFO David O’Toole - Bitget
Guess which ASX stock could rise 35% - The Motley Fool Australia
AVITA Medical to Host Investor Webinar Briefing - Yahoo Finance
AVITA Medical, Inc. (NASDAQ:RCEL) Is Expected To Breakeven In The Near Future - Moomoo
Investors Can Question AVITA Medical Executives on Aug. 12 - Stock Titan
Avita Medical (NASDAQ:RCEL) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Finanzdaten der Avita Medical Inc-Aktie (RCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):